MENU
+Compare
IXJ
ETF ticker: NYSE ARCA
AS OF
Jan 22, 04:59 PM (EDT)
Price
$88.55
Change
-$0.20 (-0.23%)
Net Assets
3.67B

IXJ stock forecast, quote, news & analysis

Category: @Health
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for IXJ with price predictions
Jan 08, 2025

IXJ's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for IXJ turned positive on January 03, 2025. Looking at past instances where IXJ's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IXJ's RSI Indicator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on IXJ as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in of 337 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for IXJ entered a downward trend on January 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG).

Industry description

The investment seeks to track the S&P Global 1200 Health Care IndexTM. The fund generally invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that the index provider deems to be a part of the healthcare sector of the economy and that the index provider believes are important to global markets.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF ETF is 87.49B. The market cap for tickers in the group ranges from 64.65K to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF ETF was 11%. For the same ETF, the average monthly price growth was 20%, and the average quarterly price growth was 44%. ISRG experienced the highest price growth at 12%, while CRL experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF ETF was 11%. For the same stocks of the ETF, the average monthly volume growth was -60% and the average quarterly volume growth was -4%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 51
P/E Growth Rating: 57
Price Growth Rating: 48
SMR Rating: 60
Profit Risk Rating: 57
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
IXJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
1-800-474-2737
Web
www.ishares.com